Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
Occlutech is one of the leading companies in its field, with several major products including state-of-the-art PFO occluders
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Dec 20
Occlutech is one of the leading companies in its field, with several major products including state-of-the-art PFO occluders
21 Dec 20
Collaboration strengthens Peijia's position for competing in untapped market and supports global expansion of HighLife's technology
21 Dec 20
eMurmur is a digital health company specializing in machine learning for the analysis of digital auscultation data
18 Dec 20
Abbott's HeartMate 3 heart pump approved for use for pediatric patients battling advanced heart failure and the life-saving…
16 Dec 20
New algorithmic module provides automated expert-level assessment of heart function for point-of-care medical teams enabling a quick and…
15 Dec 20
Tria mitral valve will incorporate a new biopolymer, dubbed LifePolymer, to resist calcification, and bear stresses and strains
11 Dec 20
Astral-4LV is a multicentre clinical trial, planned to enrol 152 patients in France, Germany, Italy, Netherlands, Portugal, Spain,…
11 Dec 20
Paradise system is catheter-based system designed to denervate the renal nerves with ultrasound energy.
10 Dec 20
Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room
08 Dec 20
Royal Papworth Hospital is one of the leading centres in a study on the efficacy of Boston Scientific's…